The role of MPTP in Parkinson's disease: Connecting brain and gut?

Experimental Neurology

Volumn 210, Issue 2, 2008, Pages 281-285

  Goetze, O ^a   Woitalla, D ^a  

^a ST JOSEF HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ALPHA SYNUCLEIN; DOPAMINE;

ARTICLE; DISEASE MODEL; DOPAMINE RELEASE; HUMAN; INTESTINE INNERVATION; LEWY BODY; NERVE DEGENERATION; NEUROPATHOLOGY; NEUROTRANSMITTER RELEASE; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EID: 41149136540     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2008.01.004     Document Type: Note

References (48)

1. Abbott R.D., Petrovitch H., White L.R., Masaki K.H., Tanner C.M., Curb J.D., Grandinetti A., Blanchette P.L., Popper J.S., and Ross G.W. Frequency of bowel movements and the future risk of Parkinson's disease. Neurology 57 (2001) 456-462
2. Ahlskog J.E. I can't get no satisfaction: still no neuroprotection for Parkinson disease. Neurology 69 (2007) 1476-1477
3. Anderson G., Noorian A.R., Taylor G., Anitha M., Bernhard D., Srinivasan S., and Greene J.G. Loss of enteric dopaminergic neurons and associated changes in colon motility in an MPTP mouse model of Parkinson's disease. Exp. Neurol. (2007)
4. Anlauf M., Schafer M.K., Eiden L., and Weihe E. Chemical coding of the human gastrointestinal nervous system: cholinergic, VIPergic, and catecholaminergic phenotypes. J. Comp. Neurol. 459 (2003) 90-111
5. Blackshaw L.A., Brookes S.J., Grundy D., and Schemann M. Sensory transmission in the gastrointestinal tract. Neurogastroenterol. Motil. 19 (2007) 1-19
6. Braak H., Del Tredici K., Rub U., de Vos R.A., Jansen Steur E.N., and Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging 24 (2003) 197-211
7. Braak H., de Vos R.A., Bohl J., and Del Tredici K. Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology. Neurosci. Lett. 396 (2006) 67-72
8. Davies K., King D., Billington D., and Barrett J. Intestinal permeability and orocaecal transit time in elderly patients with Parkinson's disease. Postgrad. Med. J. 72 (1996) 164-167
9. Davis G.C., Williams A.C., Markey S.P., Ebert M.H., Caine E.D., Reichert C.M., and Kopin I.J. Chronic Parkinsonism secondary to intravenous injection of meperidine analogues. Psychiatry Res. 1 (1979) 249-254
10. De Giorgio R., Guerrini S., Barbara G., Stanghellini V., De Ponti F., Corinaldesi R., Moses P.L., Sharkey K.A., and Mawe G.M. Inflammatory neuropathies of the enteric nervous system. Gastroenterology 126 (2004) 1872-1883
11. Eaker E.Y., and Mathias J.R. MPTP and duodenal motility. Dig. Dis. Sci. 35 (1990) 665-666
12. Eaker E.Y., Bixler G.B., Dunn A.J., Moreshead W.V., and Mathias J.R. Chronic alterations in jejunal myoelectric activity in rats due to MPTP. Am. J. Physiol. Gastrointest.: Liver Physiol. 253 (1987) G809-G815
13. Eaker E., Bixler G., Dunn A., Moreshead W., and Mathias J. Dopamine and norepinephrine in the gastrointestinal tract of mice and the effects of neurotoxins. J. Pharmacol. Exp. Ther. 244 (1988) 438-442
14. Forno L.S., DeLanney L.E., Irwin I., and Langston J.W. Similarities and differences between MPTP-induced Parkinsonism and Parkinson's disease. Neuropathologic considerations. Adv. Neurol. 60 (1993) 600-608
15. Gershon M.D., Kirchgessner A.L., and Wade P.R. Functional anatomy of the enteric nervous system. In: Johnson L.R. (Ed). Physiology of the Gastrointestinal Tract 1 (1994), Raven, New York 381-422
16. Gilja O.H., Hatlebakk J.G., Odegaard S., Berstad A., Viola I., Giertsen C., Hausken T., and Gregersen H. Advanced imaging and visualization in gastrointestinal disorders. World J. Gastroenterol. 13 (2007) 1408-1421
17. Goetze O., Wieczorek J., Mueller T., Przuntek H., Schmidt W.E., and Woitalla D. Impaired gastric emptying of a solid test meal in patients with Parkinson's disease using 13C-sodium octanoate breath test. Neurosci. Lett. 375 (2005) 170-173
18. Goetze O., Steingoetter A., Menne D., van der Voort I.R., Kwiatek M.A., Boesiger P., Weishaupt D., Thumshirn M., Fried M., and Schwizer W. The effect of macronutrients on gastric volume responses and gastric emptying in humans: a magnetic resonance imaging study. Am. J. Physiol. Gastrointest.: Liver Physiol. 292 (2007) G11-G17
19. Javitch J.A., D'Amato R.J., Strittmatter S.M., and Snyder S.H. Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. Proc. Natl. Acad. Sci. U. S. A. 82 (1985) 2173-2177
20. Jost W.H., Jung G., and Schimrigk K. Colonic transit time in nonidiopathic Parkinson's syndrome. Eur. Neurol. 34 (1994) 329-331
21. Lang A.E., and Lozano A.M. Parkinson's disease. First of two parts. N. Engl. J. Med. 339 (1998) 1044-1053
22. Langston J.W., Ballard P., Tetrud J.W., and Irwin I. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219 (1983) 979-980
23. Li Z.S., Pham T.D., Tamir H., Chen J.J., and Gershon M.D. Enteric dopaminergic neurons: definition, developmental lineage, and effects of extrinsic denervation. J. Neurosci. 24 (2004) 1330-1339
24. Li Z.S., Schmauss C., Cuenca A., Ratcliffe E., and Gershon M.D. Physiological modulation of intestinal motility by enteric dopaminergic neurons and the D2 receptor: analysis of dopamine receptor expression, location, development, and function in wild-type and knock-out mice. J. Neurosci. 26 (2006) 2798-2807
25. Mangla J.C., Pihan G., Brown H.A., Rattan S., and Szabo S. Effect of duodenal ulcerogens cysteamine, mepirizole, and MPTP on duodenal myoelectric activity in rats. Dig. Dis. Sci. 34 (1989) 537-542
26. Pfeiffer R.F. Gastrointestinal dysfunction in Parkinson's disease. Lancet. Neurol. 2 (2003) 107-116
27. Polymeropoulos M.H., Lavedan C., Leroy E., Ide S.E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E.S., Chandrasekharappa S., Athanassiadou A., Papapetropoulos T., Johnson W.G., Lazzarini A.M., Duvoisin R.C., Di Iorio G., Golbe L.I., and Nussbaum R.L. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276 (1997) 2045-2047
28. Przedborski S., Kostic V., Jackson-Lewis V., Naini A.B., Simonetti S., Fahn S., Carlson E., Epstein C.J., and Cadet J.L. Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity. J. Neurosci. 12 (1992) 1658-1667
29. Przedborski S., Jackson-Lewis V., Yokoyama R., Shibata T., Dawson V.L., and Dawson T.M. Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 4565-4571
30. Przuntek H., Muller T., and Riederer P. Diagnostic staging of Parkinson's disease: conceptual aspects. J. Neural Transm. 111 (2004) 201-216
31. Qualman S.J., Haupt H.M., Yang P., and Hamilton S.R. Esophageal Lewy bodies associated with ganglion cell loss in achalasia. Similarity to Parkinson's disease. Gastroenterology 87 (1984) 848-856
32. Sakakibara R., Odaka T., Uchiyama T., Asahina M., Yamaguchi K., Yamaguchi T., Yamanishi T., and Hattori T. Colonic transit time and rectoanal videomanometry in Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 74 (2003) 268-272
33. Schemann M., and Neunlist M. The human enteric nervous system. Neurogastroenterol Motil. 16 Suppl 1 (2004) 55-59
34. Schwizer W., Steingoetter A., and Fox M. Magnetic resonance imaging for the assessment of gastrointestinal function. Scand. J. Gastroenterol. 41 (2006) 1245-1260
35. Singaram C., Ashraf W., Gaumnitz E.A., Torbey C., Sengupta A., Pfeiffer R., and Quigley E.M. Dopaminergic defect of enteric nervous system in Parkinson's disease patients with chronic constipation. Lancet 346 (1995) 861-864
36. Speciale S.G. MPTP: insights into Parkinsonian neurodegeneration. Neurotoxicol. Teratol. 24 (2002) 607-620
37. Spillantini M.G., Schmidt M.L., Lee V.M., Trojanowski J.Q., Jakes R., and Goedert M. Alpha-synuclein in Lewy bodies. Nature 388 (1997) 839-840
38. Strobel H.W. Cytochrome P450 in Neurodegeneration and Parkinson's Disease (2001), Graham Publishing, Johnson City, TN
39. Suzuki K., Mizuno Y., and Yoshida M. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-like compounds on mitochondrial respiration. Adv. Neurol. 53 (1990) 215-218
40. Szabo S. MPTP, gastroduodenal motility, duodenal ulceration, and Parkinson's disease. Dig. Dis. Sci. 35 (1990) 666-667
41. Szabo S., Brown A., Pihan G., Dali H., and Neumeyer J. Duodenal ulcer induced by MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine). Proc. Soc. Exp. Biol. Med. 180 (1985) 567-571
42. The Parkinson Study Group PRECEPT Investigators. Mixed lineage kinase inhibitor CEP-1347 fails to delay disability in early Parkinson disease. Neurology 69 (2007) 1480-1490
43. Vila M., Vukosavic S., Jackson-Lewis V., Neystat M., Jakowec M., and Przedborski S. Alpha-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the Parkinsonian toxin MPTP. J. Neurochem. 74 (2000) 721-729
44. Wakabayashi K., Takahashi H., Takeda S., Ohama E., and Ikuta F. Parkinson's disease: the presence of Lewy bodies in Auerbach's and Meissner's plexuses. Acta. Neuropathol. (Berl) 76 (1988) 217-221
45. Wakabayashi K., Takahashi H., Takeda S., Ohama E., and Ikuta F. Lewy bodies in the enteric nervous system in Parkinson's disease. Arch. Histol. Cytol. 52 (1989) 191-194 Suppl
46. Wakabayashi K., Takahashi H., Ohama E., and Ikuta F. Parkinson's disease: an immunohistochemical study of Lewy body-containing neurons in the enteric nervous system. Acta. Neuropathol. (Berl) 79 (1990) 581-583
47. Wood J., Alpers D., and Andrews P. Fundamentals of neurogastroenterology. Gut 45 (1999) 6-16
48. Wullner U., Loschmann P.A., Schulz J.B., Schmid A., Dringen R., Eblen F., Turski L., and Klockgether T. Glutathione depletion potentiates MPTP and MPP+ toxicity in nigral dopaminergic neurones. Neuroreport 7 (1996) 921-923